319 related articles for article (PubMed ID: 16305601)
1. Assessment of migraineurs referred to a specialist headache clinic in Singapore: diagnosis, treatment strategies, outcomes, knowledge of migraine treatments and satisfaction.
Soon YY; Siow HC; Tan CY
Cephalalgia; 2005 Dec; 25(12):1122-32. PubMed ID: 16305601
[TBL] [Abstract][Full Text] [Related]
2. Prevalence, pattern and predictors of use of complementary and alternative medicine (CAM) in migraine patients attending a headache clinic in Italy.
Rossi P; Di Lorenzo G; Malpezzi MG; Faroni J; Cesarino F; Di Lorenzo C; Nappi G
Cephalalgia; 2005 Jul; 25(7):493-506. PubMed ID: 15955036
[TBL] [Abstract][Full Text] [Related]
3. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues.
Cady R; Schreiber C
Headache; 2008 Jun; 48(6):900-13. PubMed ID: 18047501
[TBL] [Abstract][Full Text] [Related]
4. Underdiagnosis and undertreatment of migraine in Italy: a survey of patients attending for the first time 10 headache centres.
Cevoli S; D'Amico D; Martelletti P; Valguarnera F; Del Bene E; De Simone R; Sarchielli P; Narbone M; Testa L; Genco S; Bussone G; Cortelli P
Cephalalgia; 2009 Dec; 29(12):1285-93. PubMed ID: 19438916
[TBL] [Abstract][Full Text] [Related]
5. [Approach of neurologists in Spain to migraine: results of the CIEN-mig project (I)].
Pascual J; Sánchez del Río M; Jiménez MD; Láinez-Andrés JM; Mateos V; Leira R; Pozo-Rosich P; Guzmán-Quilo C
Rev Neurol; 2010 May; 50(10):577-83. PubMed ID: 20473832
[TBL] [Abstract][Full Text] [Related]
6. Headache diagnosis, management and morbidity in the Singapore primary care setting: findings from a general practice survey.
Khu JV; Siow HC; Ho KH
Singapore Med J; 2008 Oct; 49(10):774-9. PubMed ID: 18946609
[TBL] [Abstract][Full Text] [Related]
7. [Satisfaction of the migraine patient attending neurology clinics: results of CIEN-mig project (II)].
Pascual J; Sánchez del Río M; Jiménez MD; Láinez-Andrés J; Mateos V; Leira R; Pozo-Rosich P; Guzmán-Quilo C
Rev Neurol; 2010 Jun; 50(11):641-5. PubMed ID: 20514635
[TBL] [Abstract][Full Text] [Related]
8. [Influence of general practitioners' personal knowledge on migraine in medical attitudes towards their patients suffering from migraine].
Weber M; Daurès JP; Fabre N; Druais PL; Dardenne J; Slama A; El Hasnaoui A
Rev Neurol (Paris); 2002 Apr; 158(4):439-45. PubMed ID: 11984486
[TBL] [Abstract][Full Text] [Related]
9. [Patient satisfaction with assessment of headache by specialist consultation].
Bekkelund SI; Salvesen R
Tidsskr Nor Laegeforen; 2006 Jun; 126(12):1595-7. PubMed ID: 16770368
[TBL] [Abstract][Full Text] [Related]
10. Recognition and therapeutic management of migraine in 2004, in France: results of FRAMIG 3, a French nationwide population-based survey.
Lucas C; Géraud G; Valade D; Chautard MH; Lantéri-Minet M
Headache; 2006 May; 46(5):715-25. PubMed ID: 16643573
[TBL] [Abstract][Full Text] [Related]
11. Patients' preference for migraine preventive therapy.
Peres MF; Silberstein S; Moreira F; Corchs F; Vieira DS; Abraham N; Gebeline-Myers C
Headache; 2007 Apr; 47(4):540-5. PubMed ID: 17445103
[TBL] [Abstract][Full Text] [Related]
12. The headache management trial: a randomized study of coordinated care.
Matchar DB; Harpole L; Samsa GP; Jurgelski A; Lipton RB; Silberstein SD; Young W; Kori S; Blumenfeld A
Headache; 2008 Oct; 48(9):1294-310. PubMed ID: 18547268
[TBL] [Abstract][Full Text] [Related]
13. Recognition and management of migraine in primary care: influence of functional impact measured by the headache impact test (HIT).
De Diego EV; Lanteri-Minet M
Cephalalgia; 2005 Mar; 25(3):184-90. PubMed ID: 15689193
[TBL] [Abstract][Full Text] [Related]
14. Pharmaceutical care for migraine and headache patients: a community-based, randomized intervention.
Hoffmann W; Herzog B; Mühlig S; Kayser H; Fabian R; Thomsen M; Cramer M; Fiss T; Gresselmeyer D; Janhsen K
Ann Pharmacother; 2008 Dec; 42(12):1804-13. PubMed ID: 19001531
[TBL] [Abstract][Full Text] [Related]
15. Improvement in quality of life and activity limitations in migraine patients after prophylaxis. A prospective longitudinal multicentre study.
D'Amico D; Solari A; Usai S; Santoro P; Bernardoni P; Frediani F; De Marco R; Massetto N; Bussone G;
Cephalalgia; 2006 Jun; 26(6):691-6. PubMed ID: 16686908
[TBL] [Abstract][Full Text] [Related]
16. The impact of intensive patient education on clinical outcome in a clinic-based migraine population.
Rothrock JF; Parada VA; Sims C; Key K; Walters NS; Zweifler RM
Headache; 2006 May; 46(5):726-31. PubMed ID: 16643574
[TBL] [Abstract][Full Text] [Related]
17. Clinical features and pharmacological treatment of migraine patients referred to headache specialists in Canada.
Jelinski SE; Becker WJ; Christie SN; Giammarco R; Mackie GF; Gawel MJ; Eloff AG; Magnusson JE
Cephalalgia; 2006 May; 26(5):578-88. PubMed ID: 16674767
[TBL] [Abstract][Full Text] [Related]
18. Chronic migraine in the population: burden, diagnosis, and satisfaction with treatment.
Bigal ME; Serrano D; Reed M; Lipton RB
Neurology; 2008 Aug; 71(8):559-66. PubMed ID: 18711108
[TBL] [Abstract][Full Text] [Related]
19. What do patients want from acute migraine treatment?
Gallagher R
Cephalalgia; 2004; 24 Suppl 2():8-15. PubMed ID: 15595989
[TBL] [Abstract][Full Text] [Related]
20. Sumatriptan treatment for migraine in a health maintenance organization: economic, humanistic, and clinical outcomes.
Cohen JA; Beall D; Beck A; Rawlings J; Miller DW; Clements B; Pait DG; Batenhorst A
Clin Ther; 1999 Jan; 21(1):190-204. PubMed ID: 10090435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
